Trending News
News
News
The Most Comprehensive RNA Atlas Ever
Researchers have built one of the most comprehensive catalogs of the human transcriptome ever.
News
COVID-19 Vaccines Pre-Prepared in Syringes Can Be Safely Transported
Research demonstrates that reconstituted vaccines can be transported following minor precautions.
News
CureVac's COVID-19 Vaccine Demonstrates Interim Efficacy of 47%
The biotechnology company CureVac has announced that its Phase IIb/III clinical trial of the COVID-19 vaccine candidate CVnCoV demonstrates an interim efficacy of 47%.
News
SARS-CoV-2 May Have the Ability To Reactivate Dormant Tuberculosis
In a study, scientists found that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis in mice.
News
Next-Generation COVID-19 Vaccines Could Stimulate Another Arm of the Immune System
A new study looking at the way human cells activate the immune system in response to SARS-CoV-2 infection could open the door to even more effective and powerful vaccines against the coronavirus and its rapidly emerging variants keeping the global pandemic smoldering.
News
Exploiting the Body's "Natural Killers" To Target Breast Cancer
Researchers are using a bifunctional protein as a "bridge" between natural killer cells and breast cancer cells. This strategy could help to develop a novel breast cancer-specific immunotherapy.
News
Novavax COVID-19 Vaccine Demonstrates an Overall Efficacy of 90.4%
The biotechnology company Novavax has announced that its Phase III clinical trial of the COVID-19 vaccine NVX-CoV2373 demonstrated an overall efficacy of 90.4%.
News
Hops-Derived Compound Is a Potential Therapeutic for Common Liver Disease
Research suggests that two compounds originating from hops can help thwart a dangerous buildup of fat in the liver known as hepatic steatosis.
News
Addressing Racial Disparities in COVID-19 Vaccination
Multiple efforts aim to increase COVID-19 vaccine access and acceptance among Black, Indigenous and people of color communities.
News
Antibody Therapy Reduces Risk of Death in Severe COVID-19
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalized with severe COVID-19 who have not mounted a natural antibody response of their own.
Advertisement